新西兰考虑资助一种新的避孕药丸,使大约43 000人受益。 New Zealand considers funding a new birth control pill, benefiting around 43,000 people.

新西兰药房正在考虑从2025年4月1日起资助一种新的只使用蛋白质的避孕药 " desogestrel " (Cerazette)。 New Zealand's Pharmac is considering funding a new progestogen-only contraceptive pill, desogestrel (Cerazette), starting April 1, 2025. 与其它药丸相比,这项行动可为大约43 000人带来好处,为每日摄取提供更宽的12小时窗口。 This move could benefit around 43,000 people, offering a wider 12-hour window for daily intake compared to other pills. 公众可在2024年6月医药预算增加6.04亿美元后提出这项提议。 The public can provide feedback until February 18, and this proposal comes after a $604 million increase in the medicine budget in June 2024.